The paper examines 8519 publications on clinical pharmacology research in India as covered in Scopus database during 2005-14, using various quantitative and qualitative parameters with a focus on its growth, citation quality, share of national international collaborative papers, subject-wise distribution, contribution and contribution and impact of its leading scholars, contribution to most productive journals, etc.India's global publication share in clinical pharmacology was 4.80, which increased from 2.65% to 6.69% from 2005-09 to 2010-14. India's publications in clinical pharmacology witness an annual average growth rate of 25.89% and citation per paper of 6.75 during 2005-14, which decreased from 9.14 to 4.08 from 2005-09 to 2010-14. Nearly 61% of the Indian publications onclinical pharmacology registered citations from 0 to 605 citations and these citations witnessed highly skewed distribution. India's share of international collaborative publications in the total output was 12.22% during 2005-14, which decreased from 13.99% to 11.76% from 2005-09 to 2010-14. The top 15 most productive Indian organizations and authors together contributed 19.25% and 4.71% and 29.06% and 8.39% share of the cumulative publications and citations output of India in clinical pharmacology during 2005-14. The 10 most productive journals in India's clinical pharmacology research together contributed 33.82% share to the total India's publication output in clinical pharmacology during 2005-14. India's publication output in clinical pharmacology had on 51 highly cited papers (receiving 100 or more citations) and together received 8597 citations, leading to average citation per paper of 168.57.
INTRODUCTION
Clinical pharmacology is defined as the science of drugs and their clinical use, with added focus on the application of pharmacological principles and quantitative methods. Its scope varies from the discovery of new target molecules to the effects of drug usage in populations and connects the gap between medical practice and laboratory science. Its main objective is to promote the safety of prescription, maximize the drug effects and minimize the side effects. It is important that there be association with pharmacists skilled in areas of drug information, medication safety and other aspects of pharmacy practice related to clinical pharmacology. Clinical pharmacologists evaluate the evidence and produce new data through well designed studies. Clinical pharmacologists must have access to enough outpatients for clinical care, teaching and education, and research as well is supervised by medical specialists. Their responsibilities to patients include, but are not limited to analyzing adverse drug effects, therapeutics, and toxicology including reproductive toxicology, cardiovascular risks, peri-operative drug management and psychopharmacology. In addition, the application of genetic, biochemical, or viro-therapeutical techniques has led to a clear appreciation of the mechanisms involved in drug action. The various branches of clinical pharmacology include: (i) Pharmacodynamics -finding out what drugs do to the body and how, including not just the cellular and molecular aspects, but also more relevant clinical measurements; (ii) Pharmacokinetics -what happens to the drug while in the body, involving the body systems for handling the drug, usually divided into the following classification:Absorption, Distribution, Metabolism and Excretion; (iii) Rational Prescribing -using the right medication, at the right dose, using the right route and frequency of administration for the patient, and stopping the drug appropriately; (iv) Adverse Drug Effects, (v) Toxicology, (vi) Drug interactions and (vii) Drug development -usually culminating in some form of clinical trial. 1 Clinical pharmacologists focus is on developing and understanding new drug therapies and they work in a variety of settings in academia, industry and government: (i) In the laboratory setting, they study biomarkers, pharmacokinetics, drug metabolism and genetics, (ii) In the office setting, they design and evaluate clinical trials, create and implement regulation guidelines for drug use, and look at drug utilization on local and global scales and (iii) In the clinical setting, they work directly with patients, participate in experimental studies, and investigate adverse reactions and interactions. 2 Clinical pharmacology was developed as a discipline in the 1960s in USA, Europe, and UK. [3] [4] [5] At the same time, clinical pharmacology began in India due to efforts of stalwarts like Dr. U.K. Sheth, Dr. Ranjit Roy chaudhary, Dr. P. L. Sharma, and many others. 6 In the past 50 years or more, the discipline has grown very fast. However, now there is an enormous need of trained clinical pharmacologists. The pharmaceutical industry has prospered. There is generic pharmaceutical industry, which is multibillion dollar in business in India. 7 With changes in patent laws and drug regulations, large numbers of clinical trials are being done in developing countries, on drugs developed in other countries as well as on new drugs developed by local industry and academia. 8 On the other hand, in the public health scenario, there are several government and even industry initiatives to expand the coverage of healthcare and reach medicines to rural areas. 9 To meet industry needs, there has been a great rush to develop clinical trials sites, contract research organizations, and bioavailability centers. But, there is need to provide training in clinical pharmacology and clinical research to contribute to public health, hospital practice, and ethical drug development process. 
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OBJECTIVES
The main objectives of this study are to study the performance of Indian research in clinical pharmacology research during 2005-14, based on publications covered in Scopus database. In particular, the study focuses on the following objectives: (i) To study the growth of world and Indian research output and the citation impact of the Indian research; (ii) To study the global publication share of top 15 most productive countries and the place of India in global output; (iii) To study the international collaboration share and the contribution of leading foreign countries in India's collaborative output; (iv) To identify significant keywords; (v) To study the publication productivity and citation impact of 15 most productive organizations and authors; (vii) To study the medium of communication and characteristics of high cited papers.
METHODOLOGY
The study retrieved and downloaded the publication data of the world and of 15 most productive countries in clinical pharmacology from the Scopus database (http://www.scopus.com) for 10 years during 2005-14. The data on clinical pharmacology in India was downloaded using the following three search strategies. In the first search strategy publication data on Indian pharmacological output was searched using "India" in Affiliation Country tag and then limit to subject area "Pharmacology" and limit to period "2005-2014". In the second search strategy all publi cations on clinical research was searched in India using keyword "Clinical" in "Article, Title, Abstract, Keywords" tag and "India" in Affiliation Country tag and limit to time period "2005-14". In the final and third search strategy the above two search strategy was combined to get publication output on clinical pharmacology in India. The 3 rd search became our main search string. When the main search string with restricted to 15 most productive countries in "country tag", as shown below, the publication data on 15 productive countries were obtained. When the main search string is further restricted to "subject area tag", "country tag", "source title tag", "journal title name" and "affiliation tag", we got information on distribution of publications by subject, collaborating countries and organization-wise, etc. For citation data, citations to publications were also collected from date of publication till the end of (Table 1) . Of the 8519 publications in clinical pharmacology during 2005-14, 75.43% (6426) appeared as articles, 18.86% (1607) as reviews, 2.86% (244) as letters, and the rest less than 1%: editorials (0.80%), conference papers (0.70%), short surveys (0.65%), notes (0.41%), book chapters and articles in press (0.13% each) and erratum (0.02%). (Table 8) .
Profile of Top 15 Most Productive Authors
Medium of Communication
Citation Distribution of Papers
Only 60.89% of the Indian publications (3332) onclinical pharmacology were cited, receiving 100 to 605 citations since their publication till October 2015. Citation distribution of Indian clinical pharmacology publications (5187) was highly skewed: Nearly 44.59% (3799) publications accounted for 1 to 10 citations per paper (23.277% citation share). Around 58.59% (4991) publications accounted for 11 to 50 citations per paper (68.97% citation share). And 1.73% (147) publications accounted for 51 to 100 citations (17.14% citation share). The remaining 0.58% (49) publications accounted for more than 7978 citations (13.88% citation share) ( Table 2) .
International Collaboration
The share of international collaborative publications in India's clinical pharmacology research output was 12.22% during 2005-14, which decreased from 13.99% during 2005-09 to 11.76% during 2010-14 (Table 1) . India has collaborated with several countries in clinical pharmacology research during 2005-14. Among the collaborating countries, the largest share (43.52%) was contributed by United States, followed by UK (12.10%), Australia (6.44%), Canada (6.24%), Malaysia (6.15%), Saudi Arabia (5.96%), Belgium (5.86%), Germany (5.67%), Switzerland (5.48%) and South Korea (5.84%) during 2005-14. The international collaborative publications share of foreign countries in India's publications output increased by 5.59% in Saudi Arabia, followed by Malaysia (4.94%), Belgium (3.62%), South Korea (3.55%), Australia (3.05%) and Switzerland (0.78%), as against decrease by 6.08% in USA, followed by U.K. (3.25%), Canada (2.27%) and Germany (1.24%) from 2005-09 to 2010-14 (Table 3) .
Global Publication Share & Citation Impact of Top 15 Most Productive Countries
The global research output in clinical pharmacology originated in more than 100 countries during 2005-14. Table 2 lists the output of top 10 most productive countries in clinical pharmacology during 2005-14. The publication share of 10 most productive countries in clinical pharmacology varied from 3.64% to 32.70% during 2005-14, with highest publication share (32.70%) coming from USA, followed by U.K. (8.74% share), China (7.37%), Germany (6.28%), Italy (5.79%), Japan (4.82%), India (4.04%), Spain (3.88%), France (3.70%) and Canada (3.64%) during 2005-14. The global publication share has increased by 5.07% in China, followed by India (4.04%), Italy (0.15%) and France (0.12%), as against decrease by 1.44% by USA, Germany (0.97%), U.K. (0.78%), Canada (0.59%), Spain (0.45%) and Japan (0.17%) from 2005-09 to 2010-14 (Table 4 ).
Significant Keywords
Around 70 significant keywords have identified in clinical pharmacology research literature, which throw light on the nature of research undertaken in Indian organizations in this area. These significant keywords are listed in Table 5 along with their frequency of occurrence (5). 
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